EXCEED THE SPACE PROVIDED. The objectives of the five year program are three, namely, the Recruitment, Admission and Retention (RAR) at Temple University School of Medicine of academically qualified underrepresented minority students. The program will allow underrepresented minority students the opportunity to gain exposure to research activities focusing in those areas of interest to the NIH-HLBI prior to gaining acceptance to, as well as after successfully completing the first year at Temple University School of Medicine. Research exposure will be offered primarily through the Department of Physiology and the Sol Sherry Thrombosis Research Center at Temple University School of Medicine. The geographic area targeted for the selection of participants will be primarily (in order of priority) North Philadelphia, Philadelphia, Pennsylvania as well as surrounding states including New York, New Jersey, Delaware and Maryland. In' addition to exposure to research, participants will be able to participate in other academic activities to develop a more competent work force in medicine. The program will be structured as a summer program during the months of June, July and August. The structure of the program can be divided into four different phases (stipends are requested for Phase I and Phase IV). Phases II and II are already in existence and are funded. During Phase 1(10stipends requested), pre-medical undergraduate students will be selected to participate in the program at the completion of their sophomore year. Participants who complete the program will be invited to subsequently participate, the following summer, in the already existing Future Physicians of America Program (no funds requested) which accommodates up to ten (10)students during the summer after completion of their junior year. The primary objective is to provide these students with a preparatory course to excel in the MCAT examination. These students should successfully gain access into medical school (which is already the experience of the program)) and thus be able to participate in the already existing Summer Educational Reinforcement Activity Program (SERA or Phase III,no funds requested) which introduces participants to the the first three weeks of the material presented during the the first year of medical school. Phase IV (10 stipends requested) of the program will allow a then first year medical student to do research during the summer after successful completion of the first year of medical education. The administrative structure is not complicated in nature, the Program Director (dr.DeLA Cadena) will be responsible for the identification and recruitment of program participants using the already existing infrastructure of the RAR Program. A team of funded and experienced investigators (including the Program Director's Research Mentor) will provide access to students to a research career. PERFORMANCE SITE ========================================Section End===========================================
| Isordia-Salas, Irma; Manns, Joanne M; Sainz, Irma et al. (2005) Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line. Thromb Res 116:533-43 |
